EURONEXT:ALTER
Theradiag SA
- Stock
Last Close
1.32
15/12 16:08
Market Cap
17.29M
Beta: −0.26
Volume Today
31.61K
Avg: 3K
PE Ratio
−33.61
PFCF: −10.36
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.64M - | 1.71M 4.61% | 1.87M 8.92% | 1.95M 4.21% | 1.84M 5.40% | 1.80M 2.26% | 1.86M 3.53% | 2.72M 46.06% | 2.65M 2.66% | 1.88M 29.16% | |
average payables | 1.26M - | 740.86K 41.07% | 918.79K 24.02% | 991.40K 7.90% | 1.07M 7.79% | 1.04M 2.99% | 902.27K 12.96% | 1.93M 114.13% | 2.35M 21.80% | 1.75M 25.57% | |
average receivables | 972.27K - | 1.74M 78.94% | 1.69M 2.96% | 920.76K 45.46% | 0.50 100.00% | 940.02K 188,004,900% | 940.02K 0% | 1.26M - | 2.43M 92.68% | ||
book value per share | 1.83 - | 1.18 35.37% | 1.10 6.79% | 1.04 5.24% | 0.59 43.45% | 0.54 9.18% | 0.57 6.61% | 0.56 2.28% | 0.69 22.93% | ||
capex per share | -0.13 - | -0.18 41.50% | -0.08 54.50% | -0.04 54.96% | -0.04 1.08% | -0.01 65.38% | |||||
capex to depreciation | -3.55 - | -2.51 29.30% | -0.99 60.37% | -0.44 55.93% | -0.13 69.21% | -0.19 43.35% | |||||
capex to operating cash flow | 0.18 - | 0.40 129.57% | 0.18 55.29% | 0.11 37.56% | 0.16 38.70% | 0.08 49.98% | |||||
capex to revenue | -0.09 - | -0.14 66.18% | -0.07 49.32% | -0.03 57.51% | -0.04 26.25% | -0.01 64.94% | |||||
cash per share | 0.88 - | 0.58 33.66% | 0.53 9.23% | 0.50 5.19% | 0.55 9.39% | 0.35 36.25% | 0.31 12.06% | 0.38 22.83% | 0.55 44.81% | ||
days of inventory on hand | 140.05 - | 126.98 9.33% | 148.28 16.77% | 149.90 1.10% | 131.35 12.38% | 162.03 23.36% | 137.93 14.88% | 234.70 70.16% | 101.97 56.56% | 108.21 6.12% | |
days payables outstanding | 59.50 - | 55.76 6.27% | 79.89 43.26% | 71.82 10.10% | 90.60 26.16% | 75.50 16.67% | 69.26 8.27% | 192.85 178.46% | 104.35 45.89% | 92.49 11.37% | |
days sales outstanding | 105.00 - | 78.77 24.98% | 88.87 12.83% | 0.00 100.00% | 77.00 - | 82.60 - | 69.78 15.52% | ||||
debt to assets | 0.00 - | 0.04 20,946.92% | 0.04 1.88% | 0.03 28.91% | 0.03 1.92% | 0.00 91.86% | 0.02 908.54% | 0.17 606.47% | 0.14 18.65% | 0.13 7.88% | |
debt to equity | 0.00 - | 0.07 23,707.62% | 0.06 2.78% | 0.04 29.96% | 0.06 30.75% | 0.00 92.52% | 0.04 800.87% | 0.40 913.48% | 0.23 42.20% | 0.22 5.16% | |
dividend yield | 0.01 - | ||||||||||
earnings yield | -0.12 - | -0.14 15.03% | -0.09 32.59% | -0.07 20.31% | -0.27 267.48% | -0.09 67.76% | 0.03 136.72% | -0.01 129.29% | -0.02 161.75% | ||
enterprise value | 15.40M - | 19.10M 24.02% | 28.67M 50.13% | 24.58M 14.26% | 16.94M 31.09% | 5.52M 67.43% | 8.09M 46.56% | 22.90M 183.21% | 25.83M 12.82% | -4.55M 117.63% | |
enterprise value over ebitda | -8.78 - | -7.01 20.14% | -10.23 45.89% | -16.47 61.05% | 166.97 1,113.55% | 43.93 73.69% | 11.28 74.32% | 477.96 4,137.50% | -92.38 119.33% | -18.57 79.90% | |
ev to operating cash flow | -4.67 - | -7.61 62.82% | -9.48 24.58% | -10.06 6.15% | -7.55 24.96% | -3.56 52.78% | |||||
ev to sales | 2.28 - | 2.68 17.86% | 3.79 41.20% | 2.74 27.77% | 1.87 31.70% | 0.62 66.90% | 0.84 35.52% | 2.20 162.11% | 2.32 5.60% | -0.37 116.07% | |
free cash flow per share | -0.85 - | -0.62 26.41% | -0.53 14.43% | -0.36 32.01% | -0.28 24.26% | -0.18 35.47% | |||||
free cash flow yield | -0.24 - | -0.16 32.43% | -0.11 31.72% | -0.10 13.64% | -0.12 22.62% | -0.19 56.90% | |||||
graham net net | 0.65 - | 0.25 61.03% | 0.26 1.89% | 0.06 76.49% | 0.06 3.60% | 0.16 150.50% | 0.05 67.69% | -0.18 446.31% | 0.31 274.59% | ||
graham number | 4.15 - | 3.74 10.02% | 3.31 11.26% | 2.56 22.89% | 2.90 13.30% | 1.00 65.30% | 0.69 31.46% | 0.56 19.36% | 0.95 71.66% | ||
income quality | 1.72 - | 0.85 50.80% | 1.02 20.45% | 1.17 14.97% | 0.38 67.89% | 1.97 423.03% | |||||
intangibles to total assets | 0.08 - | 0.27 223.03% | 0.26 2.99% | 0.26 1.64% | 0.11 56.01% | 0.14 25.26% | 0.21 46.90% | 0.18 12.70% | 0.18 1.81% | 0.20 12.94% | |
interest coverage | -30.38 - | -40.00 31.67% | -37.82 5.44% | -29.01 23.28% | -36.22 24.82% | -7.97 78.01% | 2.82 135.45% | -7.38 361.38% | -13.75 86.29% | -3.12 77.28% | |
interest debt per share | 0.01 - | 0.09 519.42% | 0.08 8.64% | 0.06 32.08% | 0.04 26.49% | 0.01 78.31% | 0.03 218.79% | 0.23 694.63% | 0.16 29.03% | ||
inventory turnover | 2.61 - | 2.87 10.30% | 2.46 14.36% | 2.43 1.08% | 2.78 14.13% | 2.25 18.94% | 2.65 17.48% | 1.56 41.23% | 3.58 130.18% | 3.37 5.77% | |
invested capital | 0.00 - | 0.07 23,707.62% | 0.06 2.78% | 0.04 29.96% | 0.06 30.75% | 0.00 92.52% | 0.04 800.87% | 0.40 913.48% | 0.23 42.20% | 0.22 5.16% | |
market cap | 15.89M - | 21.38M 34.59% | 31.74M 48.42% | 27.98M 11.84% | 21.78M 22.17% | 8.92M 59.02% | 10.77M 20.72% | 24.36M 126.11% | 30.89M 26.82% | ||
net current asset value | 4.30M - | 2.69M 37.40% | 3.19M 18.57% | 3.57M 11.66% | 3.46M 2.97% | 3.02M 12.75% | 2.99M 1.06% | 2.27M 23.91% | 5.53M 143.16% | 4.78M 13.58% | |
net debt to ebitda | 0.28 - | 0.84 200.78% | 1.09 30.33% | 2.28 108.12% | -47.66 2,194.47% | -27.13 43.07% | -3.75 86.18% | -30.50 713.35% | 18.09 159.30% | -18.57 202.69% | |
net income per share | -0.42 - | -0.53 25.28% | -0.44 15.51% | -0.28 37.25% | -0.63 126.98% | -0.08 86.74% | 0.04 144.06% | -0.02 166.54% | -0.06 139.72% | ||
operating cash flow per share | -0.72 - | -0.44 38.36% | -0.45 1.76% | -0.33 27.86% | -0.24 27.12% | -0.16 30.79% | |||||
payables turnover | 6.13 - | 6.55 6.69% | 4.57 30.20% | 5.08 11.24% | 4.03 20.73% | 4.83 20.00% | 5.27 9.01% | 1.89 64.09% | 3.50 84.81% | 3.95 12.83% | |
receivables turnover | 3.48 - | 4.63 33.30% | 4.11 11.37% | 8.98M 218,598,364.03% | 4.74 - | 4.42 - | 5.23 18.38% | ||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.18 - | -0.39 115.41% | -0.35 9.52% | -0.23 33.18% | -0.61 161.65% | -0.10 83.57% | 0.05 150.18% | -0.02 145.92% | -0.06 173.37% | -0.04 32.78% | |
revenue per share | 1.48 - | 1.26 14.85% | 1.13 10.22% | 1.20 6.02% | 0.96 19.93% | 0.95 1.27% | 1.02 7.50% | 1.11 8.57% | 0.85 22.85% | ||
roe | -0.23 - | -0.44 93.84% | -0.40 9.35% | -0.27 33.78% | -1.07 301.34% | -0.16 85.40% | 0.06 141.33% | -0.04 168.09% | -0.09 95.01% | -0.06 32.75% | |
roic | -0.22 - | -0.36 62.84% | -0.35 2.82% | -0.24 29.49% | -0.38 55.79% | -0.07 80.25% | 0.16 312.98% | -0.03 115.96% | -0.06 134.42% | -0.02 68.60% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 1.83 - | 1.18 35.37% | 1.10 6.79% | 1.04 5.24% | 0.59 43.45% | 0.54 9.18% | 0.57 6.61% | 0.56 2.28% | 0.69 22.93% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | 7.36M - | 3.80M 48.33% | 4.32M 13.60% | 4.68M 8.40% | 4.31M 8.07% | 3.73M 13.45% | 3.56M 4.47% | 3.01M 15.40% | 6.28M 108.44% | 5.53M 11.97% | |
tangible book value per share | 1.61 - | 0.67 58.19% | 0.65 4.07% | 0.63 3.19% | 0.29 53.42% | 0.23 22.39% | 0.42 84.70% | 0.32 23.40% | 0.48 50.53% | ||
working capital | 6.37M - | 5.12M 19.67% | 5.46M 6.66% | 6.05M 10.92% | 6.00M 0.85% | 4.94M 17.76% | 4.29M 13.09% | 5.25M 22.31% | 8.43M 60.62% | 7.76M 7.89% |
All numbers in EUR (except ratios and percentages)